Karyopharm Therapeutics Inc. (KPTI): Operating Income
-$90.71M
Year ended 2025-12-31
-$82.35M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$90.71M | n/m | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | -$119.44M | n/m | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | -$129.54M | n/m | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | -$142.20M | n/m | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | -$98.27M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$171.85M | n/m | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | -$189.28M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$179.88M | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | -$130.54M | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | -$110.73M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$119.08M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | -$75.85M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$33.95M | n/m | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | -$15.89M | n/m | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | -$10.31M | n/a | 2014-03-21, From 2011-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$90.71M | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $49.11M | +150.6% |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$72.84M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$2.54M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$51.38M | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$17.25M | n/m |
| Xencor Inc (XNCR) | 2025-12-31 | -$177.50M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$273.08M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$159.99M | n/m |
Compare KPTI, ELTP, MGNX, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗